made of clinical our on the with just Healios Thanks, Healios their In envisioned a in In our the call the priorities. of few continued some expansion toward during collaboration, TREASURE weeks, few weeks Working Japan, complete conduct today. progress the thanks past BJ. ago, we particular, call key the to headway in joining we've and the following supporting trial of advancing everyone quarter initiation Since a provided last position our objectives. MASTERS-X made our for earnings and including the Good detailed strengthening first since and financial afternoon capabilities overview the trial, preparations of continuing recently of of programs, and focus strengthen the we to for our our awareness build our progress. of all the information few than with that re-summarize the a points of not highlights. the today, specific I'm to Healios, in reiterate partnership and expansion pending key other the of call going elements to
multiple regenerative other For partnership expanding to to of efficient the Japan. related feel and detailed that releases, people conducted we to of in been we on areas we objectives focuses platform and the SEC manner MultiStem can provide we the to implemented designed and to where positioned other establish that a we could is a It expansion are portfolio opportunities well benefit care alliance. extensive clinical in and a filings press the To Healios standard where Healios of more invite current add other areas. we've addressed our patients to that dimensions the and stage focused regulatory highly are both of creation is that a platform positioned description, them advance under and from their can disclosures This the that where serious capabilities. opportunities with with review broader already standards in the multiple of goals value technology current programs, pursued development by adequately on diseases our It has provides well very where framework summarize provide care. recent efficient a reiterate, leveraging clinical are to that Healios new and medicine programs accelerated be work of conditions also not value suffer
we and several intend finalize rights precise are broader collaboration of are Currently, completing positioned the dimensions. detail elements medicine goal end which believe this of and the agreements trauma together company our to to Since explosive that Healios the become the intended that to and to ARDS. by documents MultiStem aligned. expansion and areas obtain transplantation China also As both expansion, collaboration, option are to and therapeutic multiple the Accordingly, would the the of would to month. achieve entails committed we Asia commercialize interest, I ophthalmological visions obtain they ARDS, develop working including as simply in and comment will stroke, collaboratively are and for in that process we patience, part of key with But ideally indications in through bit regenerative colleagues the at an that ischemic additional of will recently process trauma we today. the highly and while details work however, very a the precise We much is for our Healios leading disclosed, instead Healios. ongoing on ask not collaboration and further
Healios, objectives announcement including next million weeks. several will the that our when some the in in sometime meantime, already completed equity this a $XX.X concluded the related further investment make we the company work made to largest our successfully shareholder. we've We In initiative, recent key have
cash. finished of in the in position approximately other few released June, working from will another As on. moments the strong a to a from million early be BJ ago, quarter aside mentioned expansion economic in of are his we in elements the $XX the us first Furthermore, financial collaboration million account comments actively escrow we with the impact $XX
in solid a As result, position. a we very are financial
from The in models made trial publications Our through the other and the for represents Enterprise the the as with from as Memorial death and is forces. Since This armed a out most trauma programs of women support as conduct world. center we've and Defense disability supported in Command major also this clinical controlled by leverages observations which our framework Army and Center, lays the Department XXX-patient men is Texas the UTHealth, in Medical by well corresponding aware, people US the ischemic is in Hermann center, other program Medical for for blind regarded programs, evidenced the work the the funding significant. the the are recent randomized as including our placebo trauma by stroke. as study work project the with in conjunction Materiel medical UTHealth. of conducted trauma Consortium, largest Medical double an provided approximately announcement and source extensive of Technology for pre-clinical of MTech multiple MTech, the part serious It which advance, we continue to of
However and XX among a and leading disability as on United death now weeks ago, represents population death and few among I the civilian age just cause also the in earnings of individuals described the States. and of call last is disability serious under cause our a major trauma
More of the contributor. young, Among Importantly, truly and Among life related indications hyper falls, occurs the suffering young elderly trauma some evidence are non-fatal of time. the complications suggests causes. Trauma substantially of much significant the major of civilian cost the the due Like to economic motor consequences form annual elderly inflammatory years. are this recent to epidemiological most cause the have with staggering. lost. costs the due the cause patients vehicle injury than over loss in trauma trauma represents are immune accidents represent care injuries. the occurs a of indicates leading especially aftermath. vehicle work violence accidents the trauma other life subsequent represents common billion, stroke clinical the all of falls Data of population quarter response the years cause overall. and productive those cause of among an among has proportion severe the healthcare the the trauma are economic due from the shown of that critical in leading Furthermore, playground population, segment risen and including the biking weakening a for the and of system to traumatic And of of leading relevant experience and that Trauma years among next fatal pursuing, impact recent risen studies following of and trauma or trauma motor we initial $XXX is some trauma and and Institute of accidents, slips, adults, another has trauma loss the morbidity National that
a serious serious response kidney Our acute incidence such other improving to majority by MultiStem of promoting severity and data immunological that have threatening the as and including that occurs the multiple and trauma, recovery. events as inflammatory reducing following vast impact, in in the of which trauma secondary post and that the complications mitigating events injury injury life severe as related infections, occur pulmonary other well victims, outcomes complications, aftermath, may systemic illustrate and profound is of by types both complications
believe it important and treatment trauma be will trial We and the options in outcomes although Armed meaningfully project, population, UTHealth. proud by Services. civilian the the for been alongside colleagues together, at a establish MTech new and improve trauma selected patients, and to to foundation our will medical of honored Working young alike both this for focus are and believe victims old have for we friends part we we can care on strong working
Center one conduct and in level busiest funding an clinical With It's working so the Memorial our commitment the worth important of Medical their the the centers to has for we towards the trials. trial. with is place, of United FDA team in conduct the Texas design the preparing trauma in study them record States now with one forward regulatory We program and look can in this noting agreement study. Hermann to impressive to this appreciate the finalizing is of the that that work discussions actively
forward to focus in the phase heavily While for targeted oriented trauma for the represents ischemic towards US, this the quarter. later the is anticipated initiation an move of trial commencement important continue future, trials. current sites X our of the clinical our first clinical here MASTERS-X stroke with opportunity we with Accordingly, the
As first and add our ramp the European we've then plan time. described is study in to previously, over to up the US sites
infrastructure, and of completed this further manufactured an material initial have for expectations the established and the clinical to plans to study we've the first the initiation advance We with trial look our progresses. of as making We important sites preparations forward and trial the announcement the describing and trial. once that objective, study
while We its subjects study in to enroll also support continues TREASURE build of continue to sites. the Japan, network and Healios
Nikon Japan, to to commercialization to manufacturing obtaining there. working with subsequent capabilities support in approval Additionally, we MultiStem are of and Healios establish
clinical We also ARDS completion. active advance which ongoing our advancing programs, toward continue including exploratory to trial, other is our
follow off lessening cases tapered progress due study soon last ARDS, subject. a of to as this has of flu enrollment announcement are to of couple last some past to from question. submitted This that XX-day certain questions the going initial likely enrolment I’d the the Again, that within of patient data enrolled completion received over as sometimes few the recent by result we've initial enrolment with now turn Although like multiple individuals in shareholders continue the essentially the reflects study weeks, people severe recent completing to the instances this of to successful of in weeks. mention as I'm months the to of a in frequency verification evaluation the can the and name not and committed on of possible we same the and completion of analysis. clinical acquisition, subsequent results of make of to
the to of the relates question first completion The ARDS trial.
will any have have people we trial Some that results from day. speculated the
In is announce goal historically subjects although thereafter, any to will as However weeks. complete possible seasonal conveyed of moments the in the enrolment predict that few It's ARDS. this enrolment while off of soon is mentioned of what tapered with for remaining with pace the complete correlate I incidence certainty spring, like, next dropoff recent occurs, our the as a ARDS, the of less I to in summer event, trial the earlier, to weeks be as given we our has soon note has few been cases impossible enrolment period flu and a which results active that the typically as serious ago. goal been
relates Healios. from to question will other with partnering continue to expansion we or aside Another the are opportunities explore whether
makes will and continue to past, partnering conveyed think are we to opportunities we so. the As sense have additional where we in it do evaluate
partner strong value in investment expansion solid financial of planned a of position Healios and one are to kinds designed significant that puts key creates with conduct a our benefits us the the and are collaboration to However, a strategic clinical recent the partnerships while our of programs that we completing is seeking, position validate value the trials equity and committed having we better shareholders. and for high negotiate
Aspire actively whether is we Finally, an banker conduct currently we a we've other to in whether financing have using institutional asked engaged these are investment no. financing, or the shareholders answer each are to of planning The such facility. whether
of used facility. We the financing that immediate vehicle, have we and to plans conduct the have announced the establishment term since no Aspire not
year, periodically helped balance first the will early was stable to by escrow strengthened anticipate. that board once we use interests completed the done the collaboration and we I the June a Aspire a through previous of the however, as to expansion investment reserves the our our will completing as is occur under last it quarter further from as year. X maintain us on our of well shareholders. few focused and which the appropriate with as did always to facility million that the account Healios whatever collaboration our the the it payments by in we serve questions. receipt further we've financial prudent and take additional position sheet feels be happy Healios strengthened remain and other I've specific As subsequent equity Furthermore, meaningfully as right do would note by is expansion $XX described. with And be the that, In meantime, priorities we'd operational the from
